The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
Hi TC,
Hopefully, I have done just that. https://open.substack.com/pub/lemminginvestor/p/skinbiotherapeutics-plc-466?r=kcv2o&utm_campaign=post&utm_medium=web
Nick,
TBF, SA has always used the line āit would be a foolish CEO who said he would never raise funds again.ā
Letās see what he delivers, perhaps we can then judge if the company has been transformed or not. He did say next year, not next month.
Poorly worded, Nick. I meant PIs realised there would be the need for an equity raise, given they knew cash burn rate, which I believe is lower now.
I have noticed that you are now using hyperbolic language to describe the situation, which is a significant change from your previous enthusiasm as of October 24th. What has caused this change, other than the confirmation of the raise and price?
I understand that the RNS has raised several questions that need to be addressed. The company has until Christmas to provide clarity, or else it may face the consequences of a disappointed investor base that has remained loyal thus far.
https://open.substack.com/pub/lemminginvestor/p/skinbiotherapeutics-plc-466?r=kcv2o&utm_campaign=post&utm_medium=web
Mad,
There is always an element of nervousness when a share price goes into reverse. If investors think about it, they have not been forward-thinking enough. It was always clear to peeps paying attention that SBTX would need a mix of equity, CLN and debt against accretive assets acquired; SA made this clear, not once, but twice. We also knew the Company needed cash as an insurance policy against further Croda delays, so its prudent.
As for Cenkos's conspiracies, assuming there will be an equity raise, the broker is doing what needs to be done. The SP raced ahead after the interview, which I requested, not SA because I felt investors needed some TLC. SA agreed to this out of respect. However, the SP perhaps responded more than anyone anticipated, which creates a discount that may be uncomfortable, hence why the price has dropped. Given the timing of the interview and the price at the time, I am making a guess, a finger-in-the-air job, that we are over the worst. If I am right, Cenkos have done their job protecting SBTX from discount placing for friends and relations, the likely next conspiracy.
Hi Farris,
Speaking as a person of faith, I always have faith. To answer directly to your questions, yes, I have faith that progress is real and tangible this time. Imminent requires much more faith than I currently have, not least because it is out of OPTI's hands at the pace partners progress.
Have I added? I do not hold Alex and Josh, my sons, hold OPTI, as does Mike Caine. However, as I was discussing with Aquae via email yesterday, I am currently being bullied by Alex. His view is I should buy OPTI. He has a lot of conviction. I will buy back in, most likely in the New Year, at which point I will declare it. Alex will continue to take the lead on updates.
This was discussed, and further clarity to add to what TW gleaned yesterday. https://open.substack.com/pub/lemminginvestor/p/optibiotix-health-plc-ca2?r=kcv2o&utm_campaign=post&utm_medium=web
Excited! #POLB announces former #AmrytPharma execs are joining Poolbeg Pharma leadership! With their proven track record, could repeat building a $billion-dollar biopharmaš”š¬ #biotech https://lemminginvestor.substack.com
https://lemminginvestor.substack.com/
Hi Farris,
I have clarification. All good. See the note under the second video link. I hope this helps.
https://lemminginvestor.substack.com/p/skinbiotherapeutics-plc-64d
Https://twitter.com/LEMMINGINVESTOR/status/1722219988537471203
Hi All,
Iāve been a tad lazy by adding the Zoom to Alex article on the commercial update.
Have a fab weekend.
https://is.gd/1enzIx
OptiBiotix expands product range on Walmart in the USAāĀ seehttps://www.walmart.com/search?q=Optibiotix+Health&facet=brand:Optibiotix+HealthĀ
This adds to their gummies, which have been in Walmart for a while as part of Dietworks and are growing rapidly.https://www.walmart.com/ip/DietWorks-Weight-Loss-Supplements-Gummies-Raspberry-60-Count/296415342
Poolbeg Pharma PLC š¢ Poolbeg Pharma, focused on diseases with high unmet needs, is hosting an investors & analysts meeting on the POLB 001 Oncology Programme. Our main research emphasis? Tackling Cytokine Release Syndrome (CRS) - a major challenge in cancer immunotherapy treatments.
https://lemminginvestor.substack.com/p/poolbeg-pharma-plc-c48
TD,
The monthly cash burn is reducing; by how much, we do not know, but we suspect we will have a better idea by the end of November. Croda funds the clinical trials and studies related to SkinBiotix and the lysate.
In the case of any accretive acquisition, the payment will be a combination of equity, CLN, and debt. Any equity raise will likely be minimal and won't have a significant discount. In a challenging market, the last discount was just 7%. This indicates a high level of confidence in the market for SBTX, possibly due to the considerable insurance policy that Croda offers for the very near term and years after that.
I invite you to digest the most recent interviews conducted by myself, with Stuart Ashman.
https://lemminginvestor.substack.com/p/skinbiotherapeutics-plc-64d - October
https://lemminginvestor.substack.com/p/skinbiotherapeutics-plc-35b - Septeber